ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

QGEN Qiagen NV

41.65
0.57 (1.39%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Qiagen NV QGEN NYSE 普通株式
  前日比 前日比 % 現在値 時刻
0.57 1.39% 41.65 08:56:36
始値 安値 高値 終値 前日終値
41.10 41.06 41.68 41.65 41.08
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2505:05GLOBEQIAGEN expands tuberculosis portfolio with new NGS Panel to..
2024/4/0922:48GLOBEQIAGEN N.V. to release results for Q1 2024 and hold webcast
2024/4/0405:05GLOBEQIAGEN strengthens its portfolio for cancer research,..
2024/3/2605:05GLOBEQIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test..
2024/3/1905:05GLOBEQIAGEN partners with International Panel Physicians..
2024/3/1118:59GLOBEQIAGEN announces Form 20-F annual report filing for 2023..
2024/2/2807:44GLOBEQIAGEN launches AI-derived biomedical knowledge base to..
2024/2/2806:05GLOBEQIAGEN earns ACT Label for new eco-friendlier QIAwave..
2024/2/1606:05GLOBEQIAGEN earns ACT Label for new eco-friendlier QIAwave..
2024/2/0823:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/0706:05GLOBEQIAGEN exceeds outlook for Q4 2023, led by 8% CER sales..
2024/1/2600:00GLOBEQIAGEN announces partnership with Penn State University to..
2024/1/2406:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/1906:05GLOBEQIAGEN announces details for completion of synthetic share..
2024/1/1121:53GLOBEQIAGEN N.V. to release results for Q4 2023 and hold webcast
2024/1/0823:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0816:00GLOBEQIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use..
2024/1/0803:07GLOBEQIAGEN announces plans to return approximately $300 million..
2024/1/0506:05GLOBEQIAGEN to accelerate investments into QIAGEN Digital..
2024/1/0316:00GLOBEQIAGEN expands business in Middle East with new regional..
2023/12/0106:05GLOBEDNA Labs International solves significant cold cases with..
2023/11/1606:05GLOBEQIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro..
2023/11/1006:05GLOBEQIAGEN launches new QIAcuity digital PCR kits and updated..
2023/11/0706:05GLOBEQIAGEN launches complete Sample to Insight workflow for..
2023/11/0221:00PRNUSQIAGEN and Element Biosciences partner to offer complete..
2023/10/3105:05GLOBEQIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth..
2023/10/2621:00GLOBEQIAGEN and Myriad Genetics partner to advance companion..
2023/10/1000:14GLOBEQIAGEN N.V. to release results for Q3 2023 and hold webcast
2023/10/0505:05GLOBEQIAGEN launches QuantiFERON-EBV RUO assay, facilitating..
2023/9/2905:05GLOBEQIAGEN extends AI capabilities of its NGS interpretation..
2023/9/2805:05GLOBEQIAGEN reports progress toward achieving Environmental,..
2023/9/2605:05GLOBEQIAGEN enhances QIAwave portfolio with new eco-friendlier..
2023/8/2605:48EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1010:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1010:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/0905:05GLOBEQIAGEN delivers ahead of outlook for Q2 2023 with 9% CER..
2023/8/0805:05GLOBEQIAGEN receives FDA approval for companion diagnostic to..
2023/7/2705:15GLOBEBio-Rad and QIAGEN announce patent settlement and..
2023/7/2420:41GLOBEQIAGEN N.V. to release results for Q2 2023 and hold webcast
2023/7/1905:05GLOBEQIAGEN expands range of digital PCR kits and services for..
2023/6/2105:05GLOBEFBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow..
2023/6/1620:36GLOBEQIAGEN provides reminder on settlement mechanics of 2023 and..
2023/6/1605:05GLOBEQIAGEN’s QuantiFERON-TB Gold Plus shows unique clinical..
2023/6/1405:05GLOBEDanish National Genome Center selects QIAGEN for variant..
2023/5/0405:05GLOBEQIAGEN exceeds outlook for Q1 2023 with 12% CER sales growth..
2023/5/0318:30GLOBEQIAGEN welcomes U.S. Preventive Services Task Force..

最近閲覧した銘柄

Delayed Upgrade Clock